Pharmacologic agents for the treatment of acute bipolar mania

Biological Psychiatry

Volumn 48, Issue 6, 2000, Pages 539-557

  McElroy, Susan L ^a   Keck Jr , Paul E ^a  

^a UNIVERSITY OF CINCINNATI   (United States)

Author keywords

Atypical antipsychotics; Bipolar mania; Mood stabilizers; Novel antiepileptics

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; CHLORPROMAZINE; CLOZAPINE; GABAPENTIN; HALOPERIDOL; IMIPRAMINE; LAMOTRIGINE; LITHIUM; LORAZEPAM; NEUROLEPTIC AGENT; OLANZAPINE; OXCARBAZEPINE; PLACEBO; QUETIAPINE; RISPERIDONE; TIAGABINE; TOPIRAMATE; TRANQUILIZER; VALPROIC ACID; ZIPRASIDONE; ZONISAMIDE;

ADD ON THERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; CYCLING; DRUG EFFICACY; HUMAN; MANIC DEPRESSIVE PSYCHOSIS; MONOTHERAPY; MOOD; PRIORITY JOURNAL; REMISSION; REVIEW;

ACUTE DISEASE; ANTICONVULSANTS; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; CONTROLLED CLINICAL TRIALS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; HUMANS; PRACTICE GUIDELINES; RANDOMIZED CONTROLLED TRIALS;

EID: 0034666198     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(00)00961-6     Document Type: Review

References (128)

1. Altshuler LL, Keck PE Jr, McElroy SL, Suppes T, Brown ES, Denicoff K, et al (1999): Gabapentin in the acute treatment of refractory bipolar disorder. Bipolar Disord 1:61-65.
2. American Psychiatric Association (1987): Diagnostic and Statistical Manual of Mental Disorders, 3rd ed rev. Washington, DC: American Psychiatric Association.
3. American Psychiatric Association (1994): Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Washington, DC: American Psychiatric Association.
4. American Psychiatric Association Practice Guideline for the Treatment of Patients with Bipolar Disorder (1994): Am J Psychiatry 151(suppl 1):i-36.
5. Anand A., Oren D.A., Berman R.M., Cappiello A., Charney D.S. Lamotrigine treatment of lithium failure outpatient mania - a double-blind, placebo-controlled trial. Soares J.C., Gershon S. Bipolar Disorders, Abstract Book, Third International Conference on Bipolar Disorder, Pittsburgh, PA, June 17-19. 1999;23 Munksgaard, Copenhagen.
6. Ballenger J.C., Post R.M. Therapeutic effects of carbamazepine in affective illness A preliminary report . Commun Psychopharmacol. 2:1978;159-175.
7. Barbini B., Scherillo P., Benedetti F., Crespi G., Colombo C., Smeraldi E. Response to clozapine in acute mania is more rapid than that of chlorpromazine. Int Clin Psychopharmacol. 12:1997;109-112.
8. Barkin J.S., Pais V.M. Jr, Gaffney M.F. Induction of mania by risperidone resistant to mood stabilizers. Clin Psychopharmacol. 17:1997;57-58.
9. Bauer M.S., Callahan A.M., Jampala C., Petty F., Sajatovic M., Schaefer V., et al. Clinical practice guidelines for bipolar disorder from the department of veterans affairs. J Clin Psychiatry. 60:1999;9-21.
10. Ben-Menachem E. Topiramate. Levy R.H., Mattson R.H., Meldrum B.S. Antiepileptic Drugs. 1995;1063-1070 Raven, New York. 4th ed.
11. Berk M., Ichim L., Brook S. Olanzapine compared to lithium in mania A double-blind randomized controlled trial . Int Clin Psychopharmacol. 14:1999;339-343.
12. Bowden C.L., Brugger A.M., Swann A.C., Calabrese J.R., Janicak P.G., Petty F., et al. Efficacy of divalproex versus lithium and placebo in the treatment of mania. J Am Med Assoc. 271:1994;918-924.
13. Bowden C.L., Calabrese J.R., McElroy S.L., Rhodes L.J., Keck P.E., Cookson J., et al. The efficacy of lamotrigine in rapid cycling and non-rapid cycling patients with bipolar disorder. Biol Psychiatry. 45:1999;953-958.
14. Brennan M.I.W., Sandyk R., Borsook D. Use of sodium valproate in the management of affective disorders Basic and clinical aspects . Emrich H.M., Okuma T., Müller A.A. Anticonvulsants in Affective Disorders. 1984;56-65 Exerpta Medica, Amsterdam.
15. Calabrese J.R., Bowden C.L., McElroy S.L., Cookson J., Andersen J., Keck P.E. Jr, et al. Spectrum of activity of lamotrigine in treatment-refractory bipolar disorder. Am J Psychiatry. 156:1999;1019-1023.
16. Calabrese J.R., Bowden C.L., Sachs G.S., Ascher J.A., Monaghan E., Rudd G.D., et al. A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. J Clin Psychiatry. 60:1999;79-88.
17. Calabrese JR, Keck PE Jr, McElroy SL, Werkner JE (1998): Topiramate in severe treatment-refractory mania. In: The American Psychiatric Association Annual Meeting New Research Program and Abstracts, Toronto, Canada, June 2. 121-122.
18. Calabrese J.R., Kimmel S.E., Woyshville M.J., Rapport D.J., Faust C.J., Thompson P.A., et al. Clozapine for treatment-refractory mania. Am J Psychiatry. 153:1996;759-764.
19. Calabrese J.R., Rapport D.J. Mood stabilizers and the evolution of maintenance study designs in bipolar I disorder. J Clin Psychiatry. 60:(suppl 5):1999;5-13.
20. Chengappa K.N.R., Rathmore D., Levine J., Atzert R., Solai L., Parepally H., et al. Topiramate as add-on treatment for patients with bipolar mania. Bipolar Disord. 1:1999;42-53.
21. Denicoff K.D., Smith-Jackson E.E., Disney E.R., Ali S.O., Leverich G.S., Post R.M. Comparative prophylactic efficacy of lithium, carbamazepine, and the combination in bipolar disorder. J Clin Psychiatry. 58:1997;470-478.
22. Desai NG, Gangadhar BN, Channabasavanna SM, Shetty KT (1987). Carbamazepine hastens therapeutic action of lithium in mania. In: Proceedings of the International Conference on New Directions in Affective Disorders, 97.
23. Dimond K.R., Pande A.C., La Moreaux L., Pierce M.W. Effect of gabapentin on mood and well-being in patients with epilepsy. Prog Neuropsychopharmacol Biol Psychiatry. 20:1996;407-417.
24. Dunayevich E, Strakowski SM (in press): Quetiapine in treatment-resistant mania: A case report. Am J Psychiatry.
25. Dunner D.L., Fieve R.R. Clinical factors in lithium carbonate prophylaxis failure. Arch Gen Psychiatry. 30:1974;229-233.
26. Dwight M.M., Keck P.E., Stanton S.P., Strakowski S.M., McElroy S.L. Antidepressant activity and mania associated with risperidone treatment of schizoaffective disorder. Lancet. 344:1994;554-555.
27. Emrich H.M., Dose M., von Zerssen D. The use of sodium valproate, carbamazepine, and oxcarbazepine in patients with affective disorders. J Affect Disord. 8:1985;243-250.
28. Emrich H.M., von Zerssen D., Kissling W. On a possible role of GABA in mania Therapeutic efficacy of sodium valproate . Costa E., Dicharia G., Gessa G.L. GABA and Benzodiazepine Receptors. 1981;287-296 Raven, New York.
29. Fras I., Major L.F. Clinical experience with risperidone. J Am Acad Child Adolesc Psychiatry. 34:1995;833.
30. Frazier J.A., Meyer M.C., Biederman J., Wozniak J., Wilens T.E., Spencer T.J., et al. Risperidone treatment for juvenile bipolar disorder A retrospective chart review . J Am Acad Child Adolesc Psychiatry. 38:1999;960-965.
31. Freeman M.P., Stoll A.L. Mood stabilizer combinations A review of safety and efficacy . Am J Psychiatry. 155:1998;12-21.
32. Freeman T.W., Clothier J.L., Pazzaglia P., Lesem M.D., Swann A.C. A double-blind comparison of valproate and lithium in the treatment of acute mania. Am J Psychiatry. 149:1992;108-111.
33. Frye M.A., Ketter T.A., Altshuler L.L., Denicoff K., Dunn R.T., Kimbrell T.A., et al. Clozapine in bipolar disorder Treatment implications for other atypical antipsychotics . J Affect Disord. 48:1998;91-110.
34. Frye MA, Ketter TA, Kimbrell TA, Dunn RM, Speer AM, Osuch EA, et al (in press): A placebo controlled study of lamotrigine and gabapentin monotherapy in refractory mood disorders. J Clin Psychopharmacol.
35. Garfinkel P.E., Stancer H.C., Persad E. A comparison of haloperidol lithium carbonate and their combination in the treatment of mania. J Affect Disord. 2:1980;279-288.
36. Garnett WR, Pellock JM (1995): Clinical drug appraisal: Lamotrigine - effective oral add-on therapy. Pharmacy Ther March:156-170.
37. Ghaemi S.N., Katzow J.J. The use of quetiapine for treatment-resistant bipolar disorder A case series . Ann Clin Psychiatry. 11:1999;137-140.
38. Ghaemi S.N., Sachs G.S., Baldassano C.F., Truman C.J. Acute treatment of bipolar disorder with adjunctive risperidone in outpatients. Can J Psychiatry. 42:1997;196-199.
39. Goodnick P.J. Risperidone treatment of refractory acute mania. J Clin Psychiatry. 56:1995;431-432.
40. Goodwin F.K., Jamison K.R. Manic Depressive Illness. 1990;Oxford University Press, New York.
41. Goodwin F.K., Murphy D.L., Bunney W.E. Jr. Lithium-carbonate treatment in depression and mania. A longitudinal double-blind study. Arch Gen Psychiatry. 21:1969;486-496.
42. Green A.I., Tohen M., Patel J.K., Banov M., Rand C., Berman H., et al. Clozapine in the treatment of refractory psychotic mania. Am J Psychiatry. 157:2000;982-986.
43. Grossi E., Sacchetti E., Vita A., Conte G., Faravelli C., Hautman G., et al. Carbamazepine versus chlorpromazine in mania A double-blind trial . Emrich H.M., Okuma T., Müller A.A. Anticonvulsants in Affective Disorders. 1984;177-187 Excerpta Medica, Amsterdam.
44. Grunze H., Erfurth A., Amann B., Giupponi G., Kammerer C., Walden J. Intravenous valproate loading in acutely manic and depressed bipolar I patients. J Clin Psychiatry. 19:1999;303-309.
45. Grunze H., Erfurth A., Marcuse A., Amann B., Normann C., Walden J. Tiagabine appears not to be efficacious in the treatment of acute mania. J Clin Psychiatry. 60:1999;759-762.
46. Harden C.L., Pick L.H. Alterations in mood and anxiety in epilepsy patients treated with gabapentin. Epilepsia. 37:1996;137.
47. Ichim L., Berk M., Brook S. Lamotrigine compared with lithium in mania A double-blind randomized controlled trial . Ann Clin Psychiatry. 12:2000;5-10.
48. Jacobsen F.M. Risperidone in the treatment of affective illness and obsessive compulsive disorder. J Clin Psychiatry. 56:1995;423-429.
49. John V., Rapp M., Pies R. Aggression, agitation, and mania with olanzapine. Can J Psychiatry. 43:1998;1054.
50. Johnson G., Gershon S., Burdock E.I., Floyd A., Hekimian L. Comparative effects of lithium and chlorpromazine in the treatment of acute manic states. Br J Psychiatry. 119:1971;267-276.
51. Johnson G., Gershon S., Hekimian L.J. Controlled evaluation of lithium and chlorpromazine in the treatment of manic states An interim report . Compr Psychiatry. 9:1968;563-573.
52. Kanba S., Yagi G., Kamijima K., Suzuki T., Tajima O., Otaki J.-I. The first open study of Zonisamide, a novel anticonvulsant, shows efficacy in mania. Prog Neuropsychopharmacol Biol Psychiatry. 18:1994;707-715.
53. Keck PE Jr, Ice K (2000): A three-week, double-blind, randomized trial of ziprasidone in the acute treatment of mania. In: The American Psychiatric Association Annual Meeting New Research Program and Abstracts, Chicago, IL, May 16. 116-117.
54. Keck P.E. Jr, McElroy S.L., Bennett J.A. Pharmacologic loading in the treatment of acute mania. Bipolar Disord. 2:2000;42-46.
55. Keck P.E. Jr, McElroy S.L., Nemeroff C.B. Anticonvulsants in the treatment of bipolar disorder. J Neuropsychiatry Clin Neurosci. 4:1992;395-405.
56. Keck P.E. Jr, Welge J.A., McElroy S.L., Arnold L.M., Strakowski S.M. Placebo effect in randomized, controlled studies of acute bipolar mania and depression. Biol Psychiatry. 47:2000;748-755.
57. Keck P.E. Jr, Wilson D.R., Strakowski S.M., McElroy S.L., Kizer D.L., Balistreri T.M., et al. Clinical predictors of acute risperidone response in schizophrenia, schizoaffective disorder, and psychotic mood disorders. J Clin Psychiatry. 56:1995;466-470.
58. Klein D.F. Importance of psychiatric diagnosis in prediction of clinical drug effects. Arch Gen Psychiatry. 16:1967;118-126.
59. Klein E., Bental E., Lerer B., Belmaker R.H. Carbamazepine and haloperidol in excited psychoses. Arch Gen Psychiatry. 41:1984;165-170.
60. Kusumakar V, Kakshmi N, Yatham MB, O'Donovan CA, Kutcher SP (1999): Topiramate in rapid cycling bipolar women. In: The American Psychiatric Association Annual Meeting New Research Program and Abstracts, Washington, DC, May 19. 200.
61. Kusumakar V., Yatham L.N., Haslam D.R.S., Parikh S.V., Matte R., Silverstone P.H., Sharma V. Treatment of mania, mixed state, and rapid cycling. Can J Psychiatry. 42:(suppl 2):1997;79S-86S.
62. Lerer B., Moore N., Meyendorff E., Cho S.-R., Gershon S. Carbamazepine versus lithium in mania A double blind study . J Clin Psychiatry. 48:1987;89-93.
63. Licht R.N. Drug treatment of mania A critical review . Acta Psychiatr Scand. 97:1998;387-397.
64. Lindenmayer J.P., Klebanov R. Olanzapine-induced manic-like syndrome. J Clin Psychiatry. 59:1998;318-319.
65. Maggs R. Treatment of manic illness with lithium carbonate. Br J Psychiatry. 109:1963;56-65.
66. Marcotte D. Use of topiramate, a new antiepileptic as a mood stabilizer. J Affect Disord. 50:1998;245-251.
67. McElroy S.L., Frye M., Denicoff K., Altshuler L., Nolen W., Kupka R., et al. Olanzapine in treatment-resistant bipolar disorder. J Affect Disord. 49:1998;119-122.
68. McElroy S.L., Keck P.E. Jr, Pope H.G. Jr, Hudson J.I., Morris D. Correlates of antimanic response to valproate. Psychopharmacol Bull. 27:1991;127-133.
69. McElroy S.L., Keck P.E. Jr, Stanton S.P., Tugrul K.C., Bennet J.A., Strakowski S.M. A randomized comparison of divalproex oral loading versus haloperidol in the initial treatment of acute psychotic mania. J Clin Psychiatry. 57:1996;142-146.
70. McElroy S.L., Soutullo C.A., Keck P.E. Jr, Kmetz G.F. A pilot trial of adjunctive gabapentin in the treatment of bipolar disorder. Ann Clin Psychiatry. 9:1997;99-103.
71. McElroy S.L., Suppes T., Keck P.E. Jr, Frye M.A., Denicoff K.D., Altshuler L.L., et al. Open-label adjunctive topiramate in the treatment of bipolar disorders. Biol Psychiatry. 47:2000;1025-1033.
72. McIntyre R., Young L.T., Hasey G., Patelis-Siotis I., Jones B.D. Risperidone treatment of bipolar disorder. Can J Psychiatry. 42:1997;88-90.
73. Meldrum B.S. Update on the mechanism of action of antiepileptic drugs. Epilepsia. 37:(suppl):1996;4-11.
74. Möller M.J., Kissling W., Riehl T., Baumi J., Binz U., Wendt G. Double-blind evaluation of the antimanic properties of carbamazepine as a comedication to haloperidol. Prog Neuropsychopharmacol Biol Psychiatry. 13:1989;127-136.
75. Müller A.A., Stoll K.D. Carbamazepine and oxcarbazepine in the treatment of manic syndromes Studies in Germany . Emrich H.M., Okuma T., Müller A.A. Anticonvulsants in Affective Disorders. 1984;134-147 Excerpta Medica, Amsterdam.
76. Müller-Oerlinghausen B., Retzow A., Henn F.A., Giedke H., Walden J. Valproate as an adjunct to neuroleptic medication for the treatment of acute episodes of mania A prospective, randomized, double-blind, placebo-controlled multicenter study . J Clin Psychopharmacol. 20:2000;195-203.
77. Norton J., Potter D., Edwards K. Sustained weight loss associated with topiramate. Epilepsia. 38:(suppl 3):1997;58.
78. O'Croinin F., Zibin T., Holt L. Re Hypomania associated with risperidone . Can J Psychiatry. 40:1995;51.
79. Okuma T. Effects of carbamazepine and lithium on affective disorders. Neuropsychobiology. 27:1993;138-145.
80. Okuma T., Inanaga K., Otsuki S., Sarai K., Takahashi R., Itazama H., et al. Comparison of the antimanic efficacy of carbamazepine and chlorpromazine A double-blind controlled study . Psychopharmacology. 66:1979;211-217.
81. Oommen K.J., Mathews S. Zonisamide A new antiepileptic drug . Clin Neuropharmacol. 22:1999;192-200.
82. Pande AC, Crockatt JG, Janney CA, Werth JL, Gabapentin Bipolar Disorder Study Group (in press): Gabapentin in bipolar disorder. A placebo-controlled trial of adjunctive therapy. Bipolar Disord.
83. Pande A.C., Davidson J.R.T., Jefferson J.W., Janney C.A., Katzelnick D.J., Weisler R.H., et al. Treatment of social phobia with gabapentin A placebo-controlled study . J Clin Psychopharmacol. 19:1999;341-348.
84. Pande AC, Pollack MH, Crockatt J, Greiner M, Choninard G, Lydiard RB, et al (2000): Placebo-controlled study of gabapentin treatment of panic disorder. J Clin Psychopharmacol 20:467-471.
85. Platman S.R. A comparison of lithium carbonate and chlorpromazine in mania. Am J Psychiatry. 127:1970;351-353.
86. Pope H.G. Jr, McElroy S.L., Keck P.E. Jr, Hudson J.I. Valproate in the treatment of acute mania A placebo-controlled study . Arch Gen Psychiatry. 48:1991;62-68.
87. Post R.M., Ballenger J.C., Uhde T.W., Joffe R.T. Efficacy of carbamazepine in manic-depressive illness Implications for underlying mechanisms . Post R.M. Neurobiology of Mood Disorders. 1984;777-816 Williams & Wilkins, Baltimore.
88. Post R.M., Uhde T.W., Roy-Byrne P.P., Joffe R.T. Correlates of antimanic response to carbamazepine. Psychiatry Res. 21:1987;71-83.
89. Pozo P., Alcantara A.G. Mania-like syndrome in a patient with chronic schizophrenia during olanzapine treatment. J Psychiatry Neurosci. 23:1998;309-310.
90. Prien R.F., Caffey E.M. Jr, Klett C.J. Comparison of lithium carbonate and chlorpromazine in the treatment of mania. Report of the Veterans Administration and National Institute of Mental Health Collaborative Study Group. Arch Gen Psychiatry. 26:1972;146-153.
91. Reeves R.R., McBride W.A., Brannon G.E. Olanzapine-induced mania. J Am Osteopath Assoc. 98:1998;549-550.
92. Rho J.M., Sankar R. Progress in epilepsy research. The pharmacologic basis of antiepileptic drug action. Epilepsia. 40:1999;1471-1483.
93. Rosenfeld W.E., Schaefer P.A., Pace K. Weight loss patterns with topiramate therapy. Epilepsia. 38:(suppl 3):1997;60.
94. Rush A.J., Rago W.V., Crismon M.L., Toprac M.G., Shon S.P., Suppes T., et al. Medication treatment for the severely and persistently mentally ill The Texas Medication Algorithm Project . J Clin Psychiatry. 60:1999;284-291.
95. Sachs G, Risperidone Bipolar Study Group (1999, December): Safety and efficacy of risperidone vs placebo as add-on therapy to mood stabilizers in the treatment of manic phase of bipolar disorder. Presented at the 38th annual meeting of the American College of Neuropsychopharmacology, Acapulco, Mexico.
96. Sachs GS, Printz DJ, Kahn DA, Carpenter D, Docherly JP (2000): The expert consensus guideline series: Medication treatment of bipolar disorder 2000. Postgrad Med Special Rep April:1-104.
97. Sajatovic M., DiGiovanni S.K., Bastani B., Hattab H., Ramirez L.F. Risperidone therapy in treatment refractory acute bipolar and schizoaffective mania. Psychopharmacol Bull. 32:1996;55-61.
98. Schaffer C.B., Schaffer L.C. The use of risperidone in the treatment of bipolar disorder. J Clin Psychiatry. 57:1996;136.
99. Schaffer C.B., Schaffer L.C. Gabapentin in the treatment of bipolar disorder. Am J Psychiatry. 154:1997;291-292.
100. Schaffer L.C., Schaffer C.B. Tiagabine and the treatment of refractory bipolar disorder. Am J Psychiatry. 156:1999;2014-2015.
101. Schnierow B.J., Graeber D.A. Manic symptoms associated with initiation of risperidone. Am J Psychiatry. 153:1996;1235-1236.
102. Schou M., Juel-Nielson N., Stromgren E., Voldby H. The treatment of manic psychoses by administration of lithium salts. J Neurol Neurosurg Psychiatry. 17:1954;250-260.
103. Segal J., Berk M., Brook S. Risperidone compared with both lithium and haloperidol in mania A double-blind randomized controlled trial . Clin Neuropharmacol. 21:1998;176-180.
104. Shopsin B., Gerson S., Thompson H., Collins P. Psychoactive drugs in mania A controlled comparison of lithium carbonate, chlorpromazine and haloperidol . Arch Gen Psychiatry. 32:1975;34-42.
105. Singh A.N., Catalan J. Risperidone in HIV-related manic psychosis. Lancet. 344:1994;1029-1030.
106. Singh L., Field M.J., Ferris P., Hunter J.C., Oles R.J., Williams R.G., Woodruff G.N. The antiepileptic agent gabapentin (Neurontin) possesses anxiolytic-like and anti-nociceptive actions that are reversed by D-serine. Psychopharmacology (Berl). 127:1996;1-9.
107. Small J.G., Klapper M.H., Milstein V., Kellams J.J., Miller M.J., Marhenke J.D., Small I.F. Carbamazepine compared with lithium in the treatment of mania. Arch Gen Psychiatry. 48:1991;915-921.
108. Spearing M.K., Post R.M., Leverich G.S., Brandt D., Nolen W. Modification of the Clinical Global Impression (CGI) scale for use in bipolar illness (BP) The CGI-BP . Psychiatr Res. 73:1997;159-171.
109. Sporn J., Sachs G. The anticonvulsant lamotrigine in treatment-resistant manic-depressive illness. J Clin Psychopharmacol. 17:1997;185-189.
110. Spring G., Schweid D., Gray C., Steinberg J., Horwitz M. A double-blind comparison of lithium and chlorpromazine in the treatment of manic states. Am J Psychiatry. 126:1970;1306-1310.
111. Srisurapanont M., Yatham L.N., Zis A.P. Treatment of acute bipolar depression A review of the literature . Can J Psychiatry. 40:1995;533-544.
112. Stallone F., Mendlewicz J., Fieve R.R. How blind is the double-blind? An assessment in a lithium prophylaxis study. Lancet. 1:1974;619-620.
113. Stanton S.P., Keck P.E. Jr, McElroy S.L. Treatment of acute mania with gabapentin. Am J Psychiatry. 154:1997;287.
114. Stokes P.E., Shamoian C.A., Stoll P.M., Patton M.J. Efficacy of lithium as acute treatment of manic-depressive illness. Lancet. 1:1971;1319-1325.
115. Suppes T., Webb A., Paul B., Carmody T., Kraemer H., Rush A.J. Clinical outcome in a randomized 1-year trial of clozapine versus treatment as usual for patients with treatment-resistant illness and a history of mania. Am J Psychiatry. 156:1999;1164-1169.
116. Swann A.C., Bowden C.L., Calabrese J.R., Dilsaver S.C., Morris D.D. Differential effect of number of episodes of affective disorder on response to lithium or divalproex in acute mania. Am J Psychiatry. 156:1999;1264-1266.
117. Swann A.C., Bowden C.L., Morris D., Calabrese J.R., Petty F., Small J., et al. Depression during mania. Treatment response to lithium or divalproex. Arch Gen Psychiatry. 54:1997;37-42.
118. Takahashi R., Sakuma A., Itoh K., Itoh H., Kurihara M., Saito M., Watanabe M. Comparison of efficacy of lithium carbonate and chlorpromazine in mania Report of collaborative study group on treatment of mania in Japan . Arch Gen Psychiatry. 32:1975;1310-1318.
119. Taylor C.P., Gee N.S., Su T.Z., Kocsis J.D., Welty D.F., Brown J.P., et al. A summary of mechanistic hypotheses of gabapentin pharmacology. Epilepsy Res. 29:1998;233-249.
120. Tohen M, Jacobs TG, Grundy SL, Banov MC, McElroy SL, Janicak PG, et al (in press): A double-blind, placebo-con-trolled study of olanzapine in patients with acute bipolar mania. Arch Gen Psychiatry.
121. Tohen M., Sanger T.M., McElroy S.L., Tollefson G.D., Chengappa K.N.R., Daniel D.G., et al. Olanzapine versus placebo in the treatment of acute mania. Am J Psychiatry. 156:1999;702-709.
122. Tohen M., Zarate C.A. Jr, Centorrino F., Hegarty J.I., Froeschl M., Zarate S.B. Risperidone in the treatment of mania. J Clin Psychiatry. 57:1996;249-253.
123. Tomlinson W.C. Risperidone and mania. Am J Psychiatry. 153:1996;132-133.
124. Vieta E., Gasto C., Colom F., Martinez A., Otero A., Vallejo J. Treatment of refractory rapid cycling bipolar disorder with risperidone. J Clin Psychopharmacol. 18:1998;172-174.
125. Wehr T.A., Sack D.A., Rosenthal N.E., Cowdry R.W. Rapid cycling affective disorder Contributing factors and treatment responses in 51 patients . Am J Psychiatry. 145:1988;179-184.
126. Weisler R.H., Ahearn E.P., Davison J.R., Wallace C.D. Adjunctive use of olanzapine in mood disorders Five case reports . Ann Clin Psychiatry. 9:1997;259-262.
127. Zarate C.A. Jr, Narendran R., Tohen M., Greaney J.J., Berman A., Pike S., et al. Clinical predictors of acute response with olanzapine in psychotic mood disorders. J Clin Psychiatry. 59:1998;24-28.
128. Zarate C.A. Jr, Tohen M., Baldessarini R.J. Clozapine in severe mood disorders. J Clin Psychiatry. 56:1995;411-417.